Literature DB >> 2906549

Hyperprolactinaemia.

M Hartog1, M G Hull.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2906549      PMCID： PMC1834116          DOI： 10.1136/bmj.297.6650.701

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  29 in total

1.  Borderline hyperprolactinemia in infertile women: evaluation of the prolactin response to thyrotropin releasing hormone and double-blind placebo-controlled treatment with bromocriptine.

Authors:  C M Glazener; N J Kelly; M G Hull
Journal:  Gynecol Endocrinol       Date:  1987-12       Impact factor: 2.260

2.  Size heterogeneity of immunoreactive prolactin in hyperprolactinaemic serum.

Authors:  Y K Soong; K M Ferguson; G McGarrick; S L Jeffcoate
Journal:  Clin Endocrinol (Oxf)       Date:  1982-03       Impact factor: 3.478

3.  Decreased bone density in hyperprolactinemic women.

Authors:  A Klibanski; R M Neer; I Z Beitins; E C Ridgway; N T Zervas; J W McArthur
Journal:  N Engl J Med       Date:  1980-12-25       Impact factor: 91.245

4.  Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series.

Authors:  G N Burrow; G Wortzman; N B Rewcastle; R C Holgate; K Kovacs
Journal:  N Engl J Med       Date:  1981-01-15       Impact factor: 91.245

5.  Menstrual function and serum prolactin levels after long-term bromocriptine treatment of hyperprolactinaemic amenorrhoea.

Authors:  T Bergh; S J Nillius; L Wide
Journal:  Clin Endocrinol (Oxf)       Date:  1982-06       Impact factor: 3.478

6.  Prolactin concentrations in normal menstrual cycles and conception cycles.

Authors:  E A Lenton; L M Brook; O Sobowale; I D Cooke
Journal:  Clin Endocrinol (Oxf)       Date:  1979-04       Impact factor: 3.478

7.  Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.

Authors:  D L Kleinberg; G L Noel; A G Frantz
Journal:  N Engl J Med       Date:  1977-03-17       Impact factor: 91.245

8.  Bromocriptine in management of large pituitary tumours.

Authors:  J A Wass; J Williams; M Charlesworth; D P Kingsley; A M Halliday; I Doniach; L H Rees; W I McDonald; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-26

9.  Prevalence of hyperprolactinemia in anovulatory women.

Authors:  M E Greer; T Moraczewski; J S Rakoff
Journal:  Obstet Gynecol       Date:  1980-07       Impact factor: 7.661

10.  The effect in post-menopausal women of natural human and artificial oestrogens on the concentration in serum of prolactin.

Authors:  J R Andersen; E Schroeder; P E Lebech
Journal:  Acta Endocrinol (Copenh)       Date:  1980-12
View more
  2 in total

1.  Hyperprolactinemia in Women of Reproductive Age: Etiology, diagnosis, and management.

Authors:  B H Yuen
Journal:  Can Fam Physician       Date:  1992-02       Impact factor: 3.275

2.  Pituitary imaging is essential for women with moderate hyperprolactinaemia.

Authors:  P M Stewart; S Maheshwaran; J Griffith; J Li; M C Sheppard; J Olliff; J A Franklyn
Journal:  BMJ       Date:  1993-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.